In particular, it has been demonstrated that the use of 2-difluoromethylornithine (DMFO), an inhibitor of ornithine decarboxylase (ODC), interferes with the polyamine biosynthesis and slows down the development of cancer in high-risk groups but DFMO has no significant effect on preventing cancer recurrence [6]. Here, ODC1 is linked to cancer.